针对新型冠状病毒肺炎患者的雾化吸入治疗的建议_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

倪忠 ¹ ^* , 罗凤鸣 ¹ ^* , 王吉梅 ² , 刘婷婷 ¹ , 张婷夏 ¹ , 杨薇 ¹ , 王乙茹 ¹ , 徐智 ³ , 张伟 ⁴ , 王胜昱 ⁵ , 代冰 ⁶ , 李洁 ⁷ ,  葛慧青 ² ,  梁宗安；中华医学会呼吸病学分会呼吸治疗学组

1. ;
2. ;
3. ;
4. ;
5. ;
6. ;
7. ;

Corresponding author：

葛慧青, Email: gehq@zhu.edu.cn; 梁宗安；中华医学会呼吸病学分会呼吸治疗学组, Email: liangza@scu.edu.cn

Keywords：

DOI：

10.7507/1671-6205.202002006

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 倪忠, 罗凤鸣, 王吉梅, 刘婷婷, 张婷夏, 杨薇, 王乙茹, 徐智, 张伟, 王胜昱, 代冰, 李洁, 葛慧青, 梁宗安；中华医学会呼吸病学分会呼吸治疗学组. 针对新型冠状病毒肺炎患者的雾化吸入治疗的建议. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(2): 120-124. doi: 10.7507/1671-6205.202002006 Copy

1.	国家卫生健康委办公厅国家中医药管理局办公室《新型冠状病毒感染的肺炎诊疗方案 (试行第五版)》.http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2.	中华医学会呼吸病学分会呼吸治疗学组. 机械通气时雾化吸入专家共识 (草案). 中华结核和呼吸杂志, 2014, 37(11): 812-815.
3.	中华医学会临床药学分会. 雾化吸入疗法合理用药专家共识 (2019 年版). 医药导报, 2019, 38(2): 135-146.
4.	中华医学会呼吸病学分会《雾化吸入疗法在呼吸疾病中的应用专家共识》制定专家组. 雾化吸入疗法在呼吸疾病中的应用专家共识. 中华医学杂志, 2016, 96(34): 2696-2708.
5.	中国医师协会急诊医师分会. 雾化吸入疗法急诊临床应用专家共识 (2018). 中国急救医学, 2018, 38(7): 565-575.
6.	洪建国, 陈强, 陈志敏, 等. 儿童常见呼吸道疾病雾化吸入治疗专家共识. 中国实用儿科杂志, 2012, 27(4): 265-269.
7.	俞森洋. 现代呼吸治疗学. 上海: 科学技术文献出版社, 2006.
8.	雷婷婷, 赵荣生. 雾化吸入给药的临床应用现状及研究进展. 临床药物治疗杂志, 2016, 14(3): 1-5.
9.	Vassal S, Taamma R, Marty N, et al. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Am J Infect Control, 2000, 28(5): 347-351.
10.	Gamage B, Moore D, Copes R, et al. Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control, 2005, 33(2): 114-121.
11.	Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med, 1995, 122(10): 762-766.
12.	Tablan OC, Anderson LJ, Besser R, et al. Guidelines for Preventing Health Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep, 2004, 53: 1-36.
13.	Wilkinson JR, Roberts JA, Bradding P, et al. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ, 1992, 305(6859): 931-932.
14.	Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care, 2008, 53(6): 699-725.
15.	Dimich-Ward H, Wymer ML, Chan-Yeung M. Respiratory health survey of respiratory therapists. Chest, 2004, 126(4): 1048-1053.
16.	Christiani DC, Kern DG. Asthma risk and occupation as a respiratory therapist. Am Rev Respir Dis, 1993, 148(3): 671-674.

1. 国家卫生健康委办公厅国家中医药管理局办公室《新型冠状病毒感染的肺炎诊疗方案 (试行第五版)》.http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2. 中华医学会呼吸病学分会呼吸治疗学组. 机械通气时雾化吸入专家共识 (草案). 中华结核和呼吸杂志, 2014, 37(11): 812-815.
3. 中华医学会临床药学分会. 雾化吸入疗法合理用药专家共识 (2019 年版). 医药导报, 2019, 38(2): 135-146.
4. 中华医学会呼吸病学分会《雾化吸入疗法在呼吸疾病中的应用专家共识》制定专家组. 雾化吸入疗法在呼吸疾病中的应用专家共识. 中华医学杂志, 2016, 96(34): 2696-2708.
5. 中国医师协会急诊医师分会. 雾化吸入疗法急诊临床应用专家共识 (2018). 中国急救医学, 2018, 38(7): 565-575.
6. 洪建国, 陈强, 陈志敏, 等. 儿童常见呼吸道疾病雾化吸入治疗专家共识. 中国实用儿科杂志, 2012, 27(4): 265-269.
7. 俞森洋. 现代呼吸治疗学. 上海: 科学技术文献出版社, 2006.
8. 雷婷婷, 赵荣生. 雾化吸入给药的临床应用现状及研究进展. 临床药物治疗杂志, 2016, 14(3): 1-5.
9. Vassal S, Taamma R, Marty N, et al. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Am J Infect Control, 2000, 28(5): 347-351.
10. Gamage B, Moore D, Copes R, et al. Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control, 2005, 33(2): 114-121.
11. Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med, 1995, 122(10): 762-766.
12. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for Preventing Health Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep, 2004, 53: 1-36.
13. Wilkinson JR, Roberts JA, Bradding P, et al. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ, 1992, 305(6859): 931-932.
14. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care, 2008, 53(6): 699-725.
15. Dimich-Ward H, Wymer ML, Chan-Yeung M. Respiratory health survey of respiratory therapists. Chest, 2004, 126(4): 1048-1053.
16. Christiani DC, Kern DG. Asthma risk and occupation as a respiratory therapist. Am Rev Respir Dis, 1993, 148(3): 671-674.

Previous Article
新型冠状病毒肺炎患者呼吸机使用感控管理专家共识
Next Article
新型冠状病毒肺炎诊治的实验室检验路径探讨

Chinese Journal of Respiratory and Critical Care Medicine

针对新型冠状病毒肺炎患者的雾化吸入治疗的建议

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content